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OBJECTIVES: This study sought to analyze the clinical and epidemiologic characteristics of critically ill patients
who were denied intensive care unit admission due to the unavailability of beds and to estimate the direct costs
of treatment.
METHODS: A prospective cohort study was performed with critically ill patients treated in a university hospital.
All consecutive patients denied intensive care unit beds due to a full unit from February 2012 to February 2013
were included. The data collected included clinical data, calculation of costs, prognostic scores, and outcomes.
The patients were followed for data collection until intensive care unit admission or cancellation of the request
for the intensive care unit bed. Vital status at hospital discharge was noted, and patients were classified as
survivors or non-survivors considering this endpoint.
RESULTS: Four hundred and fifty-four patients were analyzed. Patients were predominantly male (54.6%), and
the median age was 62 (interquartile range (ITQ): 47 - 73) years. The median APACHE II score was 22.5 (ITQ:
16 - 29). Invasive mechanical ventilation was used in 298 patients (65.6%), and vasoactive drugs were used in
44.9% of patients. The median time of follow-up was 3 days (ITQ: 2 - 6); after this time, 204 patients were
admitted to the intensive care unit and 250 had the intensive care unit bed request canceled. The median total
cost per patient was US$ 5,945.98.
CONCLUSIONS: Patients presented a high severity in terms of disease scores, had multiple organ dysfunction
and needed multiple invasive therapeutic interventions. The study patients received intensive care with
specialized consultation during their stay in the hospital wards and presented high costs of treatment.
KEYWORDS: Intensive Care Units; Bed Occupancy; Health Services Accessibility; Direct Service Costs; Costs and
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’ INTRODUCTION
The intensive care unit (ICU) provides a continuous moni-
toring system for critically ill patients who have the potential
for recovery or are in a life-threatening situation. In recent
decades, this sector has observed a significant increase in the
demand for beds associated with the reduced mortality among
patients admitted. Additionally, an increase in the complex-
ity of diseases and number of chronic health conditions has
been reported (1). A patient who may not benefit from
treatment due to either a very good or very poor prognosis
may be rejected from the ICU. Some patients, however, may
be denied admission to the ICU due to a lack of available
beds (2), and this delay in admission has been associated
with increased mortality (3).
The concept of rapid and early care has been established
in various fields of medicine (4-6). Considering that most
acute illnesses develop in stages of physiological and organ
dysfunction, the logical step would certainly be to provide
specialized care for any critically ill patient within the
hospital, regardless of the location. This approach has been
described as an "intensive care system without walls’’ (7).
In an attempt to provide intensive care outside the
ICU environment, rapid response teams (RRTs) have been
created with the goal of early identification of the signs and
symptoms of physiological worsening in patients, thereby
reducing the risk of adverse events in inpatient units. This
strategy consists of a bedside intensive therapy system
formed usually by a doctor, nurse and physiotherapist (8).
The benefits that this system have provided to hospitalizedDOI: 10.6061/clinics/2017(09)08
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patients have been described by several authors (9-15). Most
studies have adopted ‘‘before and after’’ quasi-experimental
designs, demonstrating a reduction in adverse events in
hospitalized patients and hospital mortality. However, there
are few studies describing the care costs of critically ill
patients outside of the intensive care environment. Research
in this area is important for the financial planning of actions
in health care.
The aim of the present study was to analyze the clinical
and epidemiological characteristics of critically ill patients who
were denied ICU admission due to the unavailability of beds
and to estimate the direct costs of treatment during this period.
’ METHODS
This was a prospective cohort study of critically ill patients
who were treated outside the ICU due to a full unit and
attended by the RRT in a university hospital from February
2012 to February 2013.
The study was conducted in adult medical-surgical
admission wards at the University Hospital of the Londrina
State University (HU/UEL). The HU/UEL is a supplemen-
tary service of the State University of Londrina and is
characterized as a university public hospital, with 330 beds,
including 20 adult ICU beds. The RRT in this hospital is
composed of an intensivist physician and a physiotherapist
who are assigned exclusively to the tasks of this team. The
RRT responds to yellow and blue codes, assists in the care
of all critically ill patients denied ICU beds and evaluates
patients post-discharge from the ICU to prevent early read-
missions. For a yellow or blue code, the nurse caring for the
patient on the ward triggers a call for RRT consultation and
participates in the care of the patient together with the
two members of the RRT. During this evaluation, if there is a
need to transfer the patient to the ICU, the RRT accompanies
this intra-hospital transportation. Patients denied ICU beds
remain under the care of the local staff with the support
of the RRT. In these cases, the RRT performs two scheduled
daily evaluations of these patients to assist with medical
prescriptions, clinical decisions, therapeutic interventions,
and checking of laboratory and other exam results. If addi-
tional evaluations are needed, the local staff calls the RRT.
Triage decisions when there is a lack of a sufficient number
of ICU beds are made according to the Society of Critical
Care Medicine’s guidelines (16). The ICU request is perfor-
med in the electronic hospital system that provides the
diagnostic and clinical data of the patient. If there is no ICU
bed immediately available, the intensivist on duty with the
RRTevaluates the request and classifies the patient according
to the prioritization model (16). If there is more than one
patient in the first level of prioritization and only one bed is
available, then the length of time waiting for the ICU bed is
taken into consideration, and the ‘‘first come, first served’’
rule is applied. All adult ICU beds are made available for
ICU requests in the electronic system.
A convenience sample was obtained from all adult
patients admitted in the study period who presented with
a critical condition requiring admission to a monitored ICU
bed and who were refused admission due to lack of
availability. Patients under the age of 18 years and those
who had a waiting time for admission to the ICU of less than
24 hours were excluded.
The data collected consisted of demographic data (age and
sex) and clinical data, including the diagnosis of a critical
condition, presence of comorbidities, length of stay before
ICU admission, data for the calculation of costs and prog-
nostic scores and outcomes. The source of the data was the
patient’s records, which were consulted during their stay in
the hospital, and the data were then transcribed using
instruments designed to carry out the present research.
Each patient was followed until one of the following pri-
mary outcomes occurred: ICU admission, cancellation of the
request for the ICU due to clinical improvement or limitation
of therapeutic support, transfer to another hospital or death.
Data collection began on the day of refusal of admission to
the ICU and continued until a primary outcome occurred.
Patients were classified as survivors and non-survivors con-
sidering their vital status at hospital discharge.
The Acute Physiology and Chronic Health Evaluation
(APACHE II), Sequential Organ Failure Assessment (SOFA)
and Therapeutic Intervention Scoring System (TISS-28)
scores were collected. The APACHE II score was calculated
to characterize the severity of the study population. The SOFA
score was used to observe variations in organ dysfunction/
failure. The TISS-28 score was used to quantify therapeutic
interventions carried out during treatment outside the
ICU. Each of these scores was calculated according to their
original descriptions (17-19).
In an interim analysis, a smaller sample of patients esti-
mated to be representative was used to perform a cost
analysis. For this purpose, data were collected from patients
included in the study period from February to July 2012.
The model adopted to collect costs applied the "bottom-up"
approach, a methodology considered the gold standard, in
which the goal is to estimate costs by individual patient or by
a group of patients (20). The measurement of direct costs is
then generated, and the sum of the costs can provide a
conservative estimate of the true value of treating a health
problem (21). For the present study, the direct costs gene-
rated for the treatment of patients were divided into four
categories: clinical support, consumer items, human resources
and hospital fees.
1. Clinical support: costs related to pharmacy needs (oint-
ments, body oil, strips for verification of blood sugar
and items for pressure ulcer prevention), renal support,
laboratory, laboratory tests, imaging and complementary
examinations.
2. Consumer items: costs of medication, nutrition, blood and
its derivatives.
3. Human resources: medical procedures and physical
therapists.
4. Hospital fees: considered a fixed daily rate, independent
of the type of disease.
Items from the clinical support category were analyzed
according to the medical prescription. For the calculation of
medication costs, a standard dose was considered, calculated
as the mean daily prescription for a patient of 70 kg body
weight. In the category of human resources, values were
attributed to medical procedures performed as well as the
physiotherapy service, which was divided into motor and
respiratory therapy, as noted in the medical record. In the
category of hospital fees, the values of the daily hospital
fees and intensivist doctor on duty with the RRT were com-
puted. Costs related to the use of equipment, infrastructure,
electricity, security systems, information technology, and
non-clinical support and indirect costs (lost productivity, etc.)
were not analyzed.
569
CLINICS 2017;72(9):568-574 Caring for patients outside intensive care units
Urizzi F et al.
After data collection, a value was assigned to all items. The
values were obtained from standard tables and index values
for medical procedures outlined by the Brazilian Medical
Association (BMA) (22). For items of hospital consumption,
medications and solutions, the Brasíndice price list (23)
version 799, year 2014, was used. Subsequently, the values
were translated into US dollars (US$) based on the average
price of currency for the year 2013.
Comorbidities were defined according to the criteria
published in the Charlson comorbidity index (24). The need
for ICU admission was classified as one of the following:
respiratory failure; hemodynamic instability; metabolic dis-
order, postoperative; cardiac monitoring; neurological mon-
itoring; or other. The diagnosis of infection was based on
clinical, microbiological and imaging results, and the source
of infection was classified as lung, urinary tract, blood-
stream, abdominal, surgical site or other. The diagnosis and
classification of sepsis used the Third International Con-
sensus Definitions for sepsis and septic shock (25). Sepsis
was defined as life-threatening organ dysfunction caused by
a dysregulated host response to infection, and septic shock
was defined as a subset of sepsis in which particularly
profound circulatory, cellular, and metabolic abnormalities
were associated with a greater risk of mortality than with
sepsis alone.
Statistical analysis
Data were analyzed using SPSS version 19.0 (Armonk,
NY: IBM Corp.) and MedCalc version 15 (MedCalc Soft-
ware, Mariakerke, Belgium); the significance level was 5%,
and the confidence interval was 95%. Continuous quan-
titative variables were described after the normality of
the distribution was verified with the Shapiro-Wilk test.
For variables that presented a normal distribution, the
mean and standard deviation were calculated; otherwise,
the median and interquartile range (ITQ) (25th percentile -
75th percentile) were calculated. The nominal categorical
variables were described as absolute and relative frequencies
(%) of each variable. Categorical variables were compared
using Pearson’s chi-square test (w2) or Fisher’s exact test,
where over 20% of the expected frequencies in the tables
were lower than five. Continuous variables were compared
using Student’s t-test or the Mann-Whitney test according to
the data distribution. The area under the receiver operating
characteristic (ROC) curve was calculated to evaluate the
accuracy and compare the performance of the APACHE II,
SOFA and TISS-28 to discriminate survivors and non-
survivors. The areas under the ROC curve of the indices
were compared in pairs using a non-parametric approach,
based on the difference between the areas and standard error.
Ethical approval and consent to participate
This study was approved by the Ethics Committee for
Research Involving Human Beings, State University of
Londrina/Northern Paraná Regional University Hospital,
as Opinion No. 281/2010, December 17, 2010, CAAE No.
0255.0.268.000-10. The ethics committee waived the need for
informed consent.
’ RESULTS
During the study period, 675 critically ill patients had
ICU bed requests denied and were cared for in the hospital
wards with intensivist consultation by the RRT. There were
221 patients excluded as follows: 60 patients were under
18 years of age, 102 patients spent less than 24 hours waiting
for the ICU bed, and 59 patients were considered losses due
to a lack of sufficient information in the medical records to
complete the case report form. In total, 454 patients were
evaluated. Among the patients studied, data collection on
direct costs was performed for 151 during the period from
February to July 2012.
Of the 454 patients included in the study, 54.6% were
male, and the median age was 62 (47-73) years. The median
APACHE II severity score was 22.5 (16-29). Organ dysfunc-
tion measured by the SOFA score at study entry presented a
median of 8 (4-10), and the SOFA score at the time of primary
outcome was 8 (4-13). At this point, 159 patients (35%)
presented a SOFA outcome lower than the SOFA score at
study entry; for 53 patients (11.7%), this score did not change
during the analysis, and for 242 patients (53.3%), the SOFA
outcome score was higher in relation to study entry. The
median score for therapeutic interventions (TISS-28) at study
entry was 27 (21-30).
Regarding the sector of origin, 65% of patients were cared
for in the emergency room, 34.8% in the general wards and
0.2% in the operating room. According to the diagnostic
categories of the APACHE II system, 92.3% of patients
were considered clinical, and 7.7% were surgical. For the
diagnosis at the time of requesting an ICU bed, according to
the standardization of the APACHE II system, sepsis was the
most frequent diagnosis (62.2%), followed by the principal
"cardiovascular" system (12.8%), the principal "neurological"
system (10%), postoperative conditions (3.2%) and other
diagnoses (11.8%).
A diagnosis of infection was present in 366 (80.6%)
patients at some time during the study period, and the
identified sources of infection were the lungs (76.5%), urinary
system (9%), abdominal area (6%), skin and soft tissue (5.2%),
and the bloodstream, surgical site or other source (3.3%).
Regarding the classification of infections, 198 patients pre-
sented septic shock, 158 had sepsis, and 10 had a localized
infection.
In 39% of cases, the reason for ICU admission was
respiratory failure, followed by hemodynamic instability
(36.3%), neurological monitoring (14.5%), cardiac monitoring
(7.0%) and postoperative care (2.9%). The most frequent
comorbidities were hypertension (19.3%), diabetes mellitus
(18.5%), congestive heart failure (14.5%), cirrhosis (8.4%),
chronic renal failure (6.6%), immunosuppression (6.1%) and
other (26.6%).
Mechanical ventilation was required in 298 patients
(65.6%) at some point while they waited for an ICU vacancy,
and of the 156 patients who were on spontaneous ventila-
tion, 91 required respiratory support with oxygen therapy.
When mechanical ventilation was initiated, an intensivist
physiotherapist was assigned to care for the patient and
consult in cases of any difficulties regarding this interven-
tion. The need for therapeutic interventions was associated
with higher mortality (Table 1).
In relation to the treatment of hemodynamic instability,
44.9% of patients used vasopressors or inotropic agents,
including norepinephrine (36.1%), adrenaline (4.2%), dobu-
tamine (3.1%) and dopamine (1.5%). On the other hand,
5.9% of patients required the use of vasodilators, including
sodium nitroprusside (3.3%) and nitroglycerin (2.6%), and
14.9% of patients required the use of multiple vasoactive
drugs at some point during the study period.
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Of the therapeutic interventions in these patients, 51 patients
required procedures that are usually performed in an ICU
but needed to be carried out in the hospital wards, such as
tracheal intubation, insertion of a transvenous pacemaker,
hemodialysis, and insertion of a chest tube. In addition,
150 patients required intra- or inter-hospital transporta-
tion for the performance of diagnostic or therapeutic
procedures.
Of the 454 patients analyzed, 204 (44.9%) were admitted to
the ICU after a waiting period of 3 days (2-6). Two patients
(0.4%) were transferred to another hospital, and 25 patients
(5.5%) had therapeutic support limited after agreement by
the head doctor and family because they presented an
irreversible clinical condition and therapeutic interventions
were considered futile. While waiting for an ICU bed, 101
patients (22.3%) died and 122 patients (26.9%) had their ICU
admission requests canceled due to clinical improvement.
The demographic characteristics and prognostic scores
of the group of patients whose data were collected for the
calculation of direct costs were no different from those of the
other patients in the study. Patients not included in the cost
analysis stayed longer in the hospital, but the period of cost
analysis was similar. Patients included in cost analysis also
required vasoactive drugs more frequently (Table 2).
The median total cost per patient was US$ 5,945.98 (US$
3,831.98 - US$ 10,073.41), while the median daily cost was
US$ 1,618.51 (US$ 1,235.29 - US$ 2,032.40). Considering
the blocks of direct costs, the median total cost of laboratory
tests was US$ 502.82 (US$ 255.61 - US$ 778.37); medical
procedures, US$ 81.81 (US$ 0.00 - US$ 525.28); medications,
US$ 4,342.51 (US$ 2,452.17 - US$ 7,713.01); and clinical
support, US$ 298.71 (US$ 45.64 - US$ 551.78). In addition, the
costs in accordance with outcomes were analyzed (survivors
and non-survivors), and there was a higher resource con-
sumption of medicines in patients who died (US$ 4,532.12
[US$ 2,698.91 - US$ 9,022.49]) than among those who were
discharged alive (US$ 3,594.37 [US$ 1,231.11 - US$ 6,136.93]),
p=0.009. The same finding was observed in relation to the
total costs, with a median of US$ 6,159.26 (US$ 4,038.63 - US$
11,257.26) in non-survivors and US$ 5,015.29 (US$ 2,845.04 -
US$ 8,207.94) in survivors, p=0.041 (Table 3). To compare the
day-by-day costs between survivors and non-survivors, the
results for the first seven days of observation are presented in
Figure 1. The results showed that the median daily cost was
higher in non-survivors.
’ DISCUSSION
The present study describes the care of critically ill patients
outside the ICU in the hospital wards, which is becoming a
common reality for hospitals around the world. Caring for
these patients with daily intensivist consultations and the aid
of an RRT was a local solution to increase safety for these
hospitalized patients. These patients required mechanical
ventilation, vasoactive drugs and invasive procedures, and
they received such assistance outside of a monitored ICU
bed. This situation is associated with high costs of care and
possibly with an increase in adverse events.
There are few studies in the literature evaluating the level
of care and outcomes of critically ill patients treated outside
the ICU. Previous studies (26,27) have described the benefits
of transfer to an ICU bed in a period of up to three days and
have shown that patients with an APACHE II score above
16 benefit the most from early admission (up to 3 days) to an
ICU (27). Usually, the critically ill patient is identified and
treated by the RRT and promptly transferred to an ICU to
receive continued care. However, it is also possible that the
RRT continues to provide critical care for patients who are
denied ICU admission and remain in the hospital wards
awaiting ICU bed availability. Unfortunately, this situation is
becoming increasingly frequent, particularly in low- and
middle-income countries. Despite the attempt to provide
intensive care for patients outside the ICU in this study
institution, a small proportion of the patients became refrac-
tory to treatment after hours or days of waiting for an ICU
bed. It is possible that these patients’ clinical conditions
Table 1 - Demographic and clinical characteristics of the study patients.
All Survivors (n=154) Non-survivors (n=300) P value
Age (years) 62 (47-73) 56.5 (37-67) 64 (49.5-75) o0.001*
Males (%) 248 (54.6) 69 (44.8) 179 (59.6) 0.002w
Time before ICU (days)= 3 (2-6) 2 (2-4) 2 (2-3) 0.43*
Length of hospital stay (days) 16 (7-31) 14 (8-28) 2 (2-3) o0.001*
ICU indication
Clinical (%) 419 (92.3) 136 (88.3) 283 (94.3) 0.023w
Surgery (%) 35 (7.7) 18 (11.7) 17 (5.7)
Reason for ICU admission
Respiratory failure 177 (39) 43 (27.9) 134 (44.7) o0.001w
Hemodynamic instability 165 (36.3) 46 (29.9) 119 (39.7)
Neurological monitoring 66 (14.5) 30 (19.5) 36 (12)
Cardiac monitoring 32 (7) 27 (17.5) 5 (1.7)
Postoperative care 13 (2.9) 7 (4.5) 6 (2)
Other 1 (0.2) 1 (0.6) 0 (0)
APACHE II 22.5 (16-29) 16 (9-21) 25 (20-31) o0.001*
SOFA 8 (4-10) 4 (2-7) 9 (6-11) o0.001*
TISS-28 27 (21-30) 22 (16-28) 29 (24-32) o0.001*
VM (%) 298 (65.6) 69 (23.2) 229 (76.8) o0.001w
Vasoactive drugs (%) 204 (44.9) 35 (17.2) 169 (82.8) o0.001w
Legend: ICU - intensive care unit; APACHE II - Acute Physiology and Chronic Health Evaluation; SOFA - Sequential Organ Failure Assessment;
TISS-28 - Therapeutic Intervention Scoring System - 28; VM - mechanical ventilation.
*Mann-Whitney test;
w Fisher’s exact test;
=Period between ICU request and admission or cancellation.
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became refractory due to sub-optimal treatment provided
outside the ICU, and it is conceivable that patients may die
due to the lack of ICU beds (3).
Since most critical illnesses are time sensitive, delaying
ICU admission can lead to a worse prognosis if patients do
not have access to adequate care, but there are conflicting data
in the literature regarding this issue. Some authors describe
a 1.5% increase in the risk of death for each hour of delay
in ICU admission (3) for patients treated in hospital wards,
while others have described no change in prognosis for
surgical patients cared for in the post-anesthesia care unit (28).
The direct costs associated with the care of these patients
were high and comparable with the costs described in the
literature regarding ICU patients (26,27,29-32). In the present
study, the cost of non-surviving patients was higher than that
of survivors. Jacobs et al., in an analysis of the daily cost of
ICU patients in the UK, found that the cost of non-survivors
was higher than that of survivors, with a daily consumption
of a mean of d578.00 for all patients and d748.00 for non-
survivors (29). Other factors that determined costs included
mechanical ventilation and the APACHE II score. It was also
noted in France that the cost of non-survivors was higher
than that of survivors, with a daily average of h1,380.00 for
all patients (30). When analyzing diagnostic groups in a
multicenter study in Italian ICUs, the authors found that
patients with multiple trauma (h4,717.00), acute abdominal
issues (h3,529.00) and pneumonia or acute respiratory
distress syndrome (h3,946.00) presented the highest levels
of resource consumption (31).
In the present study, it was observed that 80.6% of the
diagnoses were related to infection and its complications.
The first and largest multicenter study conducted in Brazil on
this issue noted that the cost of treatment of septic patients was
high, and the median daily cost was higher in non-survivors
(US$ 1,094.00) compared to survivors (US$ 826.00) (32). In an
evaluation of the economic impact of implementing a hospital
protocol for sepsis, Koening et al. also noted that the mean
overall costs were higher for non-survivors (US$ 27,308.00)
than for survivors (US$ 20,021.00) (33).
In other countries, such as the United States (34), Italy (35),
Germany (36) and France (37), it has also been shown that
resource consumption was higher in non-surviving septic
patients than among survivors. Regarding this point, it is
worth noting that each country is unique in relation to its
Table 2 - Comparison of demographic and clinical characteristics of the study patients who were or were not included in the analysis of
direct costs.
In cost analysis (n=151) Not in cost analysis (n=304) P value
Age (years)* 64 (49-72) 60 (43-75) 0.32w
Males (%) 83 (55.0) 165 (54.5) 0.92=
Time before ICU (days)y 3 (2-6) 4 (2-6) 0.32w
Length of hospital stay (days) 21 (11-38.75) 14 (7-28) o0.001w
ICU indication
Clinical (%) 140 (92.7) 279 (92.1) 0.81=
Surgery (%) 11 (7.3) 24 (7.9)
Reason for ICU admission
Respiratory failure 67 (44.4) 110 (36.3) 0.40=
Hemodynamic instability 49 (32.5) 116 (38.3)
Neurological monitoring 23 (15.2) 43 (14.2)
Cardiac monitoring 10 (6.6) 22 (7.3)
Postoperative care 2 (1.3) 11 (3.6)
Other 0 (0) 1 (0.3)
APACHE II* 23 (16-29) 22 (15-28) 0.11w
SOFA (day 1)* 8 (4-11) 7 (4-10) 0.16w
TISS (day 1)* 27 (21-30) 27 (21-30) 0.43w
VM (%) 106 (70.2) 192 (63.4) 0.15=
Vasoactive drugs (%) 78 (51.7) 126 (41.6) 0.04=
Legend:
*Median (interquartile range);
wMann-Whitney test;
=Chi-square;
y Period between ICU request and admission or cancellation (period of cost analysis)
SOFA (day 1): Sequential Organ Failure Assessment at study entry
APACHE II: Acute Physiology and Chronic Health Evaluation
TISS (day 1): Therapeutic Intervention Scoring System at study entry.
Table 3 - Median cost (US$) of critically ill patients treated outside intensive care units according to the hospital outcome.
Variable Total (n=151) Survivors (n=53) Non-survivors (n=98) P value*
Laboratory tests 502.82 (255.61-778.37) 505.54 (241.74-753.81) 499.52 (272.00-821.14) 0.685
Medical procedures 81.81 (0.00-525.38) 9.26 (0.00-598.86) 81.81 (0.00-528.26) 0.551
Medications 4342.51 (2452.17-7713.01) 3594.37 (1231.11-6136.93) 4532.12 (2698.91-9022.49) 0.009
Clinical support 298.71 (45.65-551.78) 275.89 (45.65-565.69) 315.13 (39.70-549.67) 0.881
Total cost 5945.98 (3831.98-10073.41) 5015.29 (2845.04-8207.94) 6159.26 (4038.63-11257.26) 0.041
Daily cost 1618.51 (1235.29-2032.40) 1269.71 (847.76-1653.87) 1787.36 (1441.40-2280.60) o0.001
Median data (interquartile deviation)
*Mann-Whitney test.
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health system, management models, reimbursement rates
and cost components; therefore, such comparisons should be
interpreted with caution. However, this finding occurred
independent of national differences and characteristics.
The findings of the present study contribute to the plan-
ning of resource allocation, admission protocols with a pri-
oritization model, investment in staff, and training courses.
There are some limitations to the present study that should
be considered. The first is related to the analysis of a single
center; thus, interpretation of the results must be performed
with caution and be limited to institutions with similar
characteristics. The second refers to the observational design,
which may be prone to selection bias and could have affected
the results.
This study is novel in its analysis of the costs of critically ill
patients treated outside the ICU, and this contribution is the
main strength of this study. Another strength of this study
was the rigor used in the cost analysis, which applied the
methodology considered the "gold standard". Moreover, the
results are relevant, comparable and reproducible for other
institutions with the same characteristics.
Critically ill patients treated outside the ICU presented
prognostic scores that demonstrated a high degree of organ
dysfunction and required a large number of therapeutic
interventions, including vasoactive drugs and invasive
mechanical ventilation. The direct costs of treatment of
these critically ill patients were high and associated with a
poor prognosis.
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